Vibativ — Compare Prices at US & Canada Pharmacies
Compare real Vibativ prices at US and Canadian pharmacies, see official FDA uses and warnings, and find generic alternatives.
What is the typical cost of Vibativ without health insurance?
Without insurance coverage, Vibativ 750mg solution (reconstituted) generally costs around $653.43 per dose at standard retail prices. However, actual costs can vary by pharmacy location and may be lower if you compare prices across multiple providers in your area.
Is a generic version of Vibativ available?
Vibativ is available only as a brand-name medication produced by Cumberland Pharmaceuticals. A generic formulation is not currently available.
Vibativ prices at US pharmacies
Vibativ — solution reconstituted, 750mg, qty 1
| Pharmacy | Retail price | With discount card |
|---|---|---|
| Kroger Pharmacy Lowest | $690.72 | $687.72 |
| Harris Teeter Pharmacy | $690.72 | $687.72 |
| CVS Pharmacy | $706.35 | $703.35 |
| Walgreens | $726.13 | $723.13 |
| Publix | $731.58 | $728.58 |
| Walmart Neighborhood Market | $741.71 | $738.71 |
| Walmart Pharmacy | $741.71 | $738.71 |
| Costco | $745.41 | $742.41 |
Vibativ prices at Canadian pharmacies
No Canadian pharmacy pricing was found for Vibativ in our latest data pull.
Canada prices are converted to USD at time of collection and shown per tablet where available. Ordering from Canadian pharmacies is legal for personal use in most cases but subject to FDA/CBSA rules — see US vs Canada, explained.
What is Vibativ used for?
Vibativ is a glycopeptide-class antibiotic manufactured by Cumberland Pharmaceuticals and available by prescription only. The typical retail price for Vibativ 750mg solution (reconstituted) is approximately $653.43 per unit. Patients without insurance or those seeking to reduce out-of-pocket costs may find lower prices by comparing rates across different pharmacies.
Available forms
solution reconstituted
Related & alternative drugs
Warnings & interactions
This is a summary of the official FDA label text, not personalized medical advice. It does not list every possible interaction or side effect. Always tell your prescriber and pharmacist about every medicine and supplement you take.
Boxed warning
WARNING: INCREASED MORTALITY IN HABP/VABP PATIENTS WITH PRE-EXISTING MODERATE OR SEVERE RENAL IMPAIRMENT, NEPHROTOXICITY, POTENTIAL ADVERSE DEVELOPMENTAL OUTCOMES Patients with pre-existing moderate/severe renal impairment (CrCl ≤ 50 mL/min) who were treated with VIBATIV for hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia (HABP/VABP) had increased mortality observed versus vancomycin. Use of VIBATIV in patients with pre-existing moderate/severe renal impairment (CrCl ≤ 50 mL/min) should be considered only when the anticipated benefit to the patient outweighs the potential risk [see Warnings and Precautions ( 5.1 , 8.4 )].
Contraindications
4 CONTRAINDICATIONS Intravenous Unfractionated Heparin Sodium ( 4.1 , 5.5 , 7.1 ) Known hypersensitivity to VIBATIV ( 4.2 , 5.6 , 6.2 ) 4.1 Intravenous Unfractionated Heparin Sodium Use of intravenous unfractionated heparin sodium is contraindicated with VIBATIV administration because the activated partial thromboplastin time (aPTT) test results are expected to be artificially prolonged for 0 to 18 hours after VIBATIV administration [ see Warnings and Precautions ( 5.5 ) and Drug Interactions (…
Known drug interactions
7 DRUG INTERACTIONS 7.1 Drug-Laboratory Test Interactions Effects of Telavancin on Coagulation Test Parameters Telavancin binds to the artificial phospholipid surfaces added to common anticoagulation tests, thereby interfering with the ability of the coagulation complexes to assemble on the surface of the phospholipids and promote clotting in vitro . These effects appear to depend on the type of reagents used in commercially available assays. Thus, when measured shortly after completion of an infusion of VIBATIV, increases in the PT, INR, aPTT, and ACT have been observed. These effects dissipate over time, as plasma concentrations of telavancin decrease.
Pregnancy & breastfeeding
8.1 Pregnancy Risk Summary Based on findings in animal reproduction studies, VIBATIV may cause fetal harm. There are no available data on VIBATIV use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.
Vibativ, by the numbers
Additional public data points beyond retail pricing — useful context, not a price quote.
Frequently asked questions
How much does Vibativ cost without insurance?
Is there a generic version of Vibativ?
What drug class is Vibativ in?
Learn more about Vibativ
In-depth answers to common Vibativ questions, fact-checked against the sources cited in each.
How does insurance affect Vibativ pricing?
Vibativ coverage and out-of-pocket costs depend entirely on your specific insurance plan's formulary and benefits structure. Contact your insurance company directly to learn whether Vibativ is covered under your plan and what your copay or coinsurance would be. If your plan does not cover Vibativ or if the copay is high, you can compare uninsured pharmacy prices across different locations to find the most affordable option for your prescription.
Page info
Prices last checked 2026-08-21. Reviewed against FDA and DailyMed official sources — see our review process. Not a substitute for professional medical advice.